SCHEMBL20079988

SCHEMBL20079988

CC(=O)CC/C=C/c1ccc(N=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC9 Q9UKV0 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34
▸ PAM P19021 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ CYP4F2 P78329 1/20 0.32
▸ CYP4A11 Q02928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9674067 0.81 RAB9A (0.49) ALDH1A1RAB9AKMT2ACYP2C9NPC1
SCHEMBL9027791 0.79 HSD11B1 (0.53) ALDH1A1TP53KMT2ACYP1A2CYP2C9
SCHEMBL18598225 0.79 HSD11B1 (0.53) ALDH1A1TP53KMT2ACYP1A2CYP2C9
SCHEMBL3108116 0.79 PAM (0.55) ALDH1A1HDAC1HDAC8HDAC3HDAC4
SCHEMBL3108113 0.79 PAM (0.55) ALDH1A1HDAC1HDAC8HDAC3HDAC4
SCHEMBL20079993 0.75 NPC1 (0.39) ALDH1A1HSD17B10TP53CYP4F2CYP4A11
SCHEMBL19687213 0.74 ALDH1A1 (0.47) ALDH1A1HSD17B10PAMTP53TSHR
SCHEMBL18657175 0.74 ALDH1A1 (0.39) ALDH1A1HSD17B10PAMTP53TSHR
SCHEMBL13306343 0.74 MEN1 (0.52) ALDH1A1MAPK1RAB9AKMT2ANPC1
SCHEMBL19415817 0.73 GLA (0.59) ALDH1A1HSD17B10F3CYP1A2HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751076-B1 SYNTHESIS METHOD AND INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLOBENZODIAZEPINES MEDIMMUNE LTD (GB) 2018-04-25 — — EP disclosed
Send feedback